Cationic Steroidal Antimicrobials for Accelerated Wound Healing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current wound healing treatments lack effective methods to enhance the rate of healing beyond traditional antimicrobial benefits, particularly in wounds with low antimicrobial loads or without infection.

Innovation Solution

The use of cationic steroidal antimicrobial (CSA) compounds with a sterol backbone and multiple cationic groups, which are applied topically to increase fibroblastic migration and epithelial growth at the wound site, accelerating the healing process.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional antimicrobial treatments are used, then infection is controlled, but wound healing rate remains slow

Engineering Contradiction:
Improvewound healing rateVSAvoidhealing time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The patent applies parameter changes by modifying the chemical structure of steroidal compounds to create cationic steroid antimicrobials (CSAs) with multiple cationic groups. This structural modification enables the compounds to simultaneously exhibit antimicrobial activity and wound healing acceleration properties, transforming a single-function treatment into a dual-function therapy that addresses both infection control and healing rate enhancement

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The CSA compounds achieve multi-functionality by simultaneously providing antimicrobial protection and accelerating wound healing through fibroblastic migration and epithelial growth stimulation. This single agent performs multiple therapeutic functions that were previously required separate treatments, eliminating the need for combination therapies and reducing overall treatment complexity

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Reliability

If conventional wound treatments are applied, then basic care is provided, but tissue formation quality is poor

Engineering Contradiction:
Improvetissue formation qualityVSAvoidtreatment complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent modifies the chemical parameters of steroidal compounds by introducing multiple cationic groups to create CSAs with enhanced biological activity. This parameter change enables the compound to interact with multiple cellular targets simultaneously, promoting coordinated fibroblastic migration, epithelial growth, and tissue remodeling, thereby improving tissue formation quality without requiring complex multi-component treatment regimens

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS9603859B2Methods and products for increasing the rate of healing of tissue wounds
Publication Date: 2017.03.28 BRIGHAM YOUNG UNIV
  • US9603859B2 patent drawing
  • US9603859B2 patent drawing
  • US9603859B2 patent drawing

AI summary

Disclosed are methods for increasing the rate of healing of a tissue wound by administering a composition including a therapeutically effective amount of at least one cationic steroid antimicrobial (CSA). Also disclosed herein are methods of promoting wound healing in a subject in need of such promotion, comprising administering a composition comprising a therapeutically effective amount of at least one CSA. Additionally, disclosed herein are compounds and compositions comprising at least one CSA, or a pharmaceutically acceptable salt thereof, for use in the treatment of a tissue wound. Kits comprising such compositions and instructions on such methods are also contemplated herein.